The United States Viscosupplementation Market Driving Factors: Increasing Knee Osteoarthritis Prevalence

By Author: colin
Total Articles: 166
Comment this article

The United States viscosupplementation market is primarily driven by the increasing prevalence of knee osteoarthritis. Viscosupplementation products and treatments are primarily used for knee osteoarthritis patients. Knee osteoarthritis has a high prevalence rate in the United States with over 30 million Americans suffering from the condition. Knee osteoarthritis is more common in older individuals and women are more likely to develop the disease. Growing geriatric population and increasing obesity rates are some of the key factors behind the rising incidence of knee osteoarthritis in the country.

The Global United States of America Viscosupplementation Market is estimated to be valued at US$ 1.54 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the United States viscosupplementation market are Anika Therapeutics Inc., Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, and Zimmer Biomet. The key players ...
... are focusing on bringing newer generations of viscosupplementation injections with improved formulations and extended durability.

The growing demand for knee osteoarthritis treatments is also driving the United States viscosupplementation market. With rising obesity levels and aging population, the incidence of knee osteoarthritis is increasing steadily. This high prevalence provides a sizable patient pool requiring viscosupplementation treatments.

Globally, the United States accounts for the largest share in the viscosupplementation market. However, other regions are also witnessing increased adoption. Manufacturers are focusing on expanding into high growth regional markets through marketing initiatives and partnerships with local distributors. Recent regulatory approvals in new geographies will further support the global expansion of key players.

Market Drivers

The increasing prevalence of knee osteoarthritis is a major market driver in the United States viscosupplementation market space. As per estimates, over 30 million Americans suffer from the condition. Growing geriatric population and rising obesity levels are significant risk factors behind the rising OA incidence rates. With an aging population and high obesity prevalence, knee OA cases will continue rising. This growing patient pool will boost the demand for viscosupplementation injections for knee osteoarthritis treatment.

The current geopolitical situation presents both opportunities and risks for market growth in the United States of America Viscosupplementation market. The ongoing economic uncertainties and inflationary pressures caused by the war in Ukraine are expected to negatively impact discretionary healthcare spending in the short term. However, an aging population and growing disease burden of osteoarthritis presents the market a long term growth driver despite near term challenges. To capitalize on future growth opportunities, market players must diversify their supply chains to minimize risks from geopolitical disruptions and invest in new product innovations catering to lower cost tiers to make treatments affordable for a wider segment of the population.

Geographically, the North East and West Coast regions of the United States account for over half of the total viscosupplementation market value. This is due to higher disposable incomes and easier access to specialized healthcare services in states like New York, California, Massachusetts and others located in these regions. Furthermore, areas with above average elderly populations like Florida also represent major markets. As living standards and medical infrastructure continues to develop across other states, the Midwest and Southern regions are projected to witness the fastest market growth during the forecast period. Making treatments available through larger insurers and retail pharmacy chains can help accelerate penetration in the emerging markets within the United States.

California commands the largest share within the United States viscosupplementation market currently, accounting for nearly 20% of the national value currently. This can be attributed to the presence of major market players, high healthcare expenditure, large elderly demographics and favorable reimbursement protocols in the state. Texas is poised to be the fastest growing market, expanding at a CAGR of over 12% between 2024-2031. This correlates with Texas holding a disproportionately large osteoarthritic population coupled with ongoing initiatives to improve access to aging-related healthcare services.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Get more insights on this topic: https://colinwilson11.hashnode.dev/united-states-viscosupplementation-market-sees-high-growth-owing-to-increasing-knee-osteoarthritis-prevalence

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )

What Are The Key Data Covered In This United States of America Viscosupplementation  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the United States of America Viscosupplementation 's growth between 2024 and 2031.

:- Accurate calculation of the size of the United States of America Viscosupplementation  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- United States of America Viscosupplementation  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of United States of America Viscosupplementation  vendors

FAQ’s

Q.1 What are the main factors influencing the United States of America Viscosupplementation ?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top United States of America Viscosupplementation  companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the United States of America Viscosupplementation ’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?